News
Bioiberica participated in two studies to establish the standard ranges of activity of Anti-factor Xa and anti-IIa of sodium heparin organized by EDQM, which will be included in the new revision of the monograph of the European Pharmacopoeia.
A simple saliva analysis identifies genetic changes associated with rapid disease progression
Physicians can identify patients having the worst prognosis, those that are at greatest risk of needing short-term prosthetic surgery
The attendants to the Northwest veterinary congress, held in Pontevedra on June 1-2, 2013, visited Bioibericas booth, getting information about our latest products.
GOODOG snacks had its own booth at the 100x100 Mascotas pet fair, held at IFEMA (Madrid, Spain) on May 25-26, 2013.
Last May Bioiberica had a non scheduled inspection from the US FDA in its facility in Geneva (Nebraska) where the first steps of heparin sodium production are performed.